Researchers at the University of Chicago have demonstrated the use of charged nanoscale metal-organic frameworks for generating free radicals using X-rays within tumor tissue to kill cancer cells directly. The nanoscale metal-organic frameworks also can deliver immune signaling molecules to activate the immune response against tumor cells. By combining these two approaches into one easily administered "vaccine," this new technology may provide better treatment of difficult-to-treat cancers.
An official website of the United States government.